Abstract

Linked routine data to enhance health-economics analysis

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Improving management of type 1 diabetes in the UK: the Dose Adjustment For Normal Eating (DAFNE) programme as a research test-bed. A mixed-method analysis of the barriers to and facilitators of successful diabetes self-management, a health economic analysis, a cluster randomised controlled trial of different models of delivery of an educational intervention and the potential of insulin pumps and additional educator input to improve outcomes
David Rankin ... Sue Roberts
Programme Grants for Applied Research | VOL. 2
David Rankin, et. al.David Rankin ... Sue Roberts
01 Dec 2014
IMPlementing IMProved Asthma self-management as RouTine (IMP2ART) in primary care: study protocol for a cluster randomised controlled implementation trial
Vicky Hammersley ... Jessica Sheringham
Trials | VOL. 24
Vicky Hammersley, et. al.Vicky Hammersley ... Jessica Sheringham
03 Apr 2023
Health economic analyses with routinely collected basic data
F Eisele ... T Steinert
Psychiatrische Praxis | VOL. 38
F Eisele, et. al.F Eisele ... T Steinert
01 May 2011
Big Data and Health Economics: Strengths, Weaknesses, Opportunities and Threats
Brendan Collins
PharmacoEconomics | VOL. 34
Brendan CollinsBrendan Collins
21 Jun 2015
View more papers

More From: Farmeconomia. Health economics and therapeutic pathways

Paper Title
Journal
Date
Author
Optimizing Treatment of Schizophrenia: Clinical and Economical Potential for Patient Switching to Long‑Acting Injectables
Lorenzo Pradelli ... Orietta Zaniolo
Farmeconomia. Health economics and therapeutic pathways | VOL. 25
Lorenzo Pradelli, et. al.Lorenzo Pradelli ... Orietta Zaniolo
22 Apr 2024
[Cost per Responder Analysis of Filgotinib in Patients Suffering from Ulcerative Colitis]
Massimiliano Povero ... Elena Visentin
Farmeconomia. Health economics and therapeutic pathways | VOL. 25
Massimiliano Povero, et. al.Massimiliano Povero ... Elena Visentin
28 Mar 2024
[Cost-Effectiveness Analysis of Maribavir in Patients with Post-Transplant Cytomegalovirus Infection or Disease that are Refractory or Resistant to Conventional Therapy]
Tam De Lacey ... Emtiyaz Chowdhury
Farmeconomia. Health economics and therapeutic pathways | VOL. 24
Tam De Lacey, et. al.Tam De Lacey ... Emtiyaz Chowdhury
07 Dec 2023
The Importance of the Pharmacoeconomic Analyses in Drug Negotiation. A Farewell Editorial
Mario Eandi
Farmeconomia. Health economics and therapeutic pathways | VOL. 24
Mario EandiMario Eandi
04 Oct 2023
View more papers